Intellectual Property News and Reports

Medtronic, Inc. and Medtronic Vascular, Inc. (collectively, Medtronic) appeal inter partes review decisions of the Patent Trial and Appeal Board holding Medtronic failed to establish the unpatentability of various claims of U.S. Patent Nos. RE45,380; RE45,760; and RE47,379 (the patents-in-suit). Medtronic also appeals the Board’s decisions granting Teleflex Innovation S.à.r.l’s (Teleflex) motion to amend certain claims of the ’379 patent. For the following reasons, we affirm.

Download Medtronic Inc. v. Teleflex Innovations S.À.R.L.